Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid.
about
Omega-3 Polyunsaturated Fatty Acids Intake to Regulate Helicobacter pylori-Associated Gastric Diseases as Nonantimicrobial Dietary ApproachNonesterified fatty acid exposure activates protective and mitogenic pathways in vascular smooth muscle cells by alternate signaling pathways.Docosahexanoic acid-induced coronary arterial dilation: actions of 17S-hydroxy docosahexanoic acid on K+ channel activity.Dietary omega-3 polyunsaturated fatty acids alter the fatty acid composition of hepatic and plasma bioactive lipids in C57BL/6 mice: a lipidomic approach.Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cellsEffect of Dietary Docosahexaenoic Acid Supplementation on the Participation of Vasodilator Factors in Aorta from Orchidectomized Rats.Conjugated linoleic acid modulation of risk factors associated with atherosclerosisPolyunsaturated fatty acids and their effects on cardiovascular diseaseDocosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration.Docosahexaenoic Acid Inhibits Vascular Smooth Muscle Cell Proliferation Induced by Glucose Variability.Omega-3 polyunsaturated fatty acids improve endothelial function in humans at risk for atherosclerosis: A Review.The benefit of docosahexanoic acid on the migration of vascular smooth muscle cells is partially dependent on Notch regulation of MMP-2/-9.Selective and potent inhibitory effect of docosahexaenoic acid (DHA) on U46619-induced contraction in rat aorta.19,20-EpDPE, a bioactive CYP450 metabolite of DHA monoacyglyceride, decreases Ca²⁺ sensitivity in human pulmonary arteries.Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung.Continual supplementation with n-3 fatty acids does not modify plasma lipid profile in spinal cord injury patients.Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids.Docosahexaenoic acid induces ciap1 mRNA and protects human endothelial cells from stress-induced apoptosis.Dramatic accumulation of triglycerides and precipitation of cardiac hemodynamic dysfunction during brief caloric restriction in transgenic myocardium expressing human calcium-independent phospholipase A2gamma.Phytanic acid attenuates insulin-like growth factor-1 activity via nitric oxide-mediated γ-secretase activation in rat aortic smooth muscle cells: possible implications for pathogenesis of infantile Refsum disease.Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats.Dihydroxydocosahexaenoic acids of the neuroprotectin D family: synthesis, structure, and inhibition of human 5-lipoxygenase
P2860
Q26784466-4CFCC9DC-BEE4-4DD1-BC48-55E54BA00527Q33980506-4B1859A0-5A69-4115-AF05-4F8D847B4DCEQ34702424-1D5417A9-19E6-4040-830C-FC7236942224Q35054156-D4A3E31B-A34C-4BDB-9DC3-B10E41B09467Q35624387-782D190A-7B97-4AF5-A2E7-A7CE8431533BQ35833597-4F15FF1C-EBE3-45B9-9C04-159D1EF61B6EQ36897274-AFE6F6B3-F9AC-4D5D-AA2D-83BF0CCCDA37Q37284621-FB5D9D57-0F12-4FC4-A3E7-F7331A69A983Q38261562-6D04F72D-C43B-4D6B-B2D4-7F9C145FA35AQ38609268-2B9CBAED-B799-4475-A4B7-07367AE11AADQ38643427-E42ADD73-668F-4D6A-90F0-7A52C1DB3CD6Q41817555-171C5CEB-A177-4DB6-90E0-F9FB55AE7E86Q42358771-85C98BF4-5F89-4D7D-8CF7-85A847EF8055Q44753413-6662810A-B8D0-4B80-A62C-2F966C247E81Q46269195-EC763899-BC5E-4E63-8B0F-B089CD74FE97Q46444259-9CFF2EE5-39FF-4DBA-8261-E414BD434939Q46479941-6CD55E1E-F6DE-4CBF-A8FD-FF679754C2C7Q46941102-5CBFF9D9-15AB-4B12-8D8A-E7D1D9B19152Q50702131-0C06FD3C-2335-4A67-AEBD-9067D2F2811AQ51304159-468B5864-0D73-4434-A38A-3CE01E080EA4Q53098674-1F2A5E45-E80F-4195-B6C9-27E1400349CBQ57375098-E1F725F2-5233-4768-A9F9-47ABB858BF62
P2860
Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cardiovascular protective effe ...... hasis on docosahexaenoic acid.
@ast
Cardiovascular protective effe ...... hasis on docosahexaenoic acid.
@en
type
label
Cardiovascular protective effe ...... hasis on docosahexaenoic acid.
@ast
Cardiovascular protective effe ...... hasis on docosahexaenoic acid.
@en
prefLabel
Cardiovascular protective effe ...... hasis on docosahexaenoic acid.
@ast
Cardiovascular protective effe ...... hasis on docosahexaenoic acid.
@en
P2093
P356
P1476
Cardiovascular protective effe ...... hasis on docosahexaenoic acid.
@en
P2093
Masahiko Hirafuji
Masaru Minami
Naoya Hamaue
Takuji Machida
P304
P356
10.1254/JPHS.92.308
P577
2003-08-01T00:00:00Z